Minerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.

JOURNAL OF GASTROENTEROLOGY, published by SPRINGER JAPAN KK, is a premier academic journal that has been at the forefront of gastrointestinal research since its inception in 1994. With an impressive Impact Factor and ranking in the top quartile (Q1) of its category, this journal holds a significant place in the field of gastroenterology, currently ranked 12th out of 167 in Scopus, placing it in the 93rd percentile. The journal serves as an essential platform for disseminating innovative research, clinical studies, and reviews that foster advancements in the understanding and treatment of gastrointestinal diseases. Although it does not offer Open Access options, it provides researchers, clinicians, and students access to crucial insights and breakthroughs pivotal to improving patient care and outcomes in gastroenterology. With a commitment to high-quality peer-reviewed content, JOURNAL OF GASTROENTEROLOGY plays a vital role in shaping the future of gastrointestinal health and research.

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.

Gastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.

ANTICANCER RESEARCH, published by the International Institute of Anticancer Research, stands at the forefront of cancer-related scholarly communication. With ISSN 0250-7005 and E-ISSN 1791-7530, this esteemed journal has been serving the global research community since 1981, showcasing innovative research aimed at combating cancer through various therapeutic approaches and scientific inquiry. Based in Greece, the journal aims to disseminate vital findings in the fields of Cancer Research, Medicine, and Oncology, reflecting its notable categorization in the Q3 and Q2 quartiles as of 2023. Despite its rigorous peer-review process and the absence of open access, ANTICANCER RESEARCH remains a vital publication for researchers, clinicians, and students eager to stay updated on the evolving landscape of anticancer strategies. As it converges to its milestone year of 2024, the journal continues to enrich the discourse around cancer treatment and prevention, affirming its position as an essential resource for those dedicated to advancing knowledge in anticancer therapies.

Revista de Gastroenterologia de Mexico, published by Elsevier, serves as a vital platform for advancing knowledge in the field of gastroenterology. Established in Mexico, this esteemed journal boasts an open access format since 2012, promoting widespread dissemination of research findings and enhancing access for healthcare professionals and researchers worldwide. With its impact factor reflecting a growing recognition in the academic community, the journal is currently ranked in the Q3 category for Gastroenterology, indicating its relevance and contribution to the field. Spanning decades of publication history from 1947 to the present, it offers a wealth of medical insights and serves as a critical resource for those engaged in clinical practice and research. The journal aims to publish high-quality original research, reviews, and clinical studies, making it an essential resource for professionals seeking to stay at the forefront of gastroenterological advancements. Located at Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal embraces a holistic approach to gastroenterology, encouraging contributions that enrich the understanding and treatment of gastrointestinal disorders.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.

GUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.

Chinese Journal of Cancer Research, published by Chinese Journal Cancer Research Co, is a pivotal platform for disseminating significant findings in the field of oncology. Since its inception in 1988, the journal has provided a comprehensive forum for cancer research, featuring peer-reviewed articles that cover various aspects of cancer biology, prevention, diagnosis, and treatment. Although the journal's coverage is currently discontinued in Scopus and holds an HIndex that has not been specified, it is ranked in the 65th percentile in Medicine - Oncology and the 48th percentile in Biochemistry, Genetics and Molecular Biology - Cancer Research. This reflects its commitment to maintaining quality and relevance in the rapidly evolving field of cancer research. Researchers, professionals, and students are encouraged to explore its rich archive of studies and breakthroughs to enhance their understanding and further their research. For access, the publication remains instrumental for those invested in advancing the global fight against cancer.